As demand for telehealth grew, payers accelerated their development of telehealth-first plans. Now that several have launched, it is clear that bringing these plans to market requires added effort on the part of payers, but they are here to stay.
Diabetes drug costs are rising at a staggering rate, though it seems to stem more from competitor price-matching than from providing paradigm-shifting drugs. This ACHP infographic sums things up nicely.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.